Novartis AG Common Stock (NVS)

CapEx to Revenue

2.23%

Quarterly · Period ending:

NVS logo

NVS CapEx to Revenue

Latest reported2.23%
NVS Quarterly CapEx/Revenue (0.00% → 2.23%)
High-resolution chart · PNG

NVS capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Novartis AG Common Stock CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
2.2278%
2.6386%
4.653%
5.7877%
3.7611%
1.8649%
8.3419%
6.0659%
5.6557%
9.538%
3.5775%
0.9143%
8.4802%
4.2545%
4.9438%
5.3974%
4.4555%
6.7036%
7.2253%
4.0323%
4.4907%
6.7591%
7.8511%
5.0008%
3.8892%
3.7771%
5.0016%
4.5265%
3.6593%
5.4038%
6.6525%
7.3863%
5.3205%
7.1486%
7.3686%
5.271%
4.7543%
6.2198%
7.2347%
7.9329%
5.3238%
6.0034%
10.2624%
6.2475%
8.08%
5.8597%
8.4918%
7.5113%
6.8966%
5.0572%
7.3228%
7.1982%
6.5286%
4.5755%
8.0435%
5.3779%
4.9103%
4.485%
4.4879%
3.8845%
4.1262%
3.5579%
5.1438%
3.0577%
5.4358%
3.6258%
7.5618%
4.5704%
7.9594%
3.7074%
8.4171%
4.3336%
5.1319%
3.9448%
13.155%
6.6205%
6.5745%
5.6219%
12.6623%
5.3746%
4.149%
3.7301%
8.8884%
3.3573%
3.3418%
3.0241%
7.4954%
4.2086%
4.6752%
3.9012%
10.6538%
5.0081%
4.7719%
3.828%
7.2005%
4.4871%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.